Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
so you post this link as support of what you posted, that 5 ml will be due in the near future ?
The company has secured up to $ 5 million in financing and has already received the first installment through financial note., Most of the funds are from Preferred Series A shares and the rest are from financial notes.
11/9/2023 New Issuance 9 Preferred Krishna Bhat Investment Restricted
Shares acquired hrough investment in company
You know, the 5 million in financing that's talked about here ALL the time? Yes, it's supposedly non dilutive. But they will have to pay it off and with the paltry income, it's not going to cut it.
I'll take a look...
Do you need reminded? I'm only going on statements made directly by the company in press releases. https://www.accesswire.com/770109/sohm-inc-announces-the-closure-of-finances-funding-for-its-various-projects
They already donated, wake up
as usual you are wrong, have a low bid in though in case someone wants to donate....
what 5 million will come due in the near future ?
can you point that out in the quaterly ? thanks
. Another bit of reality is that 5 million $ is going to come due at some point in the near future
I've been a supporter of this ticker for a few years now but here's a bit of reality. Any start up business should be profitable with 2-3 years after that you had better consider it your hobby. Another bit of reality is that 5 million $ is going to come due at some point in the near future. I don't care who loaned the money and when that happens this poor excuse for a hobby will be sitting at trip 0. You can tell me otherwise but honestly keep that trash to yourself. If you're so confident in thus company looks like there's plenty of 11s available and I expect there are a lot more where those came from.
SHMN is busy tweeting "Did you know?" surveys on twitter that no one cares about.
The market is loving the financial numbers! Nice of SHMN to turn off comments on their pumpy tweet on how great they were. I guess they didn't want anyone to post some reality there.
this was also discussed here weeks ago, I don't want to speak for hl but I believe he agreed with me.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174065604
what's misleading are people who can't read and comprehend simple English, on purpose maybe ?
Read the Tweet, this time slowly....I'll highlight the things it seems were completely twisted by bashers and certain shareholders who tried to pump it to sell some shrs or get out completely. This was on Feb 8th, they said " over the course of several months, again there was 7 wks left in the 1'st qtr Read on,
" Dispatch Timeline: As soon as the necessary compliance for exports and samples is approved, we anticipate dispatching the orders before the end of March 2024."
so after the export approvals they anticipated to begin shipping the orders, WHICH WAS THE BIGINNING OF OVER THE COURSE OF SEVERAL MONTHS.
Subject: Exciting News – CDMO Orders for Skincare Products to the Dominican Republic!
Dear Stakeholders,
We are thrilled to announce that yesterday, we received significant CDMO (Contract Development and Manufacturing Organization) orders for the export of two of our premium skincare products to the Dominican Republic. 🌟
Key Details:
Order Status: Ongoing
Approximate Value: A whopping quarter of a million dollars over the course of several months.
Dispatch Timeline: As soon as the necessary compliance for exports and samples is approved, we anticipate dispatching the orders before the end of March 2024.
But that’s not all! We’re also excited to share that we have more CDMO orders in the pipeline for the first quarter of this year, alongside our label products. 🚀
Thank you for your continued support and stay tuned for further updates!
Baron Night
CEO
$SHMN
12:48 PM · Feb 8, 2024
·
2,643
Views
$SHMN: MDP: Even an entry level DEI hire wouldn't tweet like this...
A "CEO" who overestimated revenue by more than 300% !! 🫤
But wait...Barry has ~45 yrs of what? Selling Vitamins? And being a SoCAL Low level politician. So there's your answer.
GTFO...and let Aguilar take it from here..
Definitely last post...see you in Aug or if anything tangible happens.
SHMN likes to use the word "value" in their messaging, which is very misleading.
Approximate Value: A whopping quarter of a million dollars over the course of several months.
$SHMN: Mike: There are a few of us with our own West-Wight Potters here!
My fav sailboat [on which I learnt to sail]...
However, the ONLY folks that need to be ROWING are:-
1. Barron
2. Tony
3. Ms. Jacob
Seems like Aguilar & Gallegos are pulling their weight.
Rx Revenue won't drive the PPS higher here, as stated previously,
Unless, it's over $1M...
What's concerning is that a # was tweeted out 👇️[$250k + $xyz] and that turned out to be FALSE.
If after '45' yrs of B.S the man doesn't realize that his lies aren't working , then maybe it's time to GTFO🤨 Barry:- You can't establish Credibility with Real Bio-Tech INVESTMENT Community, if you tweet like a d-a$$ used car salesman.
Some of us were toddlers when you started your "Illustrious" 45 yr. Financial career.
**We'll find out what the 2nd QTR revs will be, in the meanwhile hoping to get news on ABBIE & Coastar [This is what will bring in real investors outside of OTC flippers]
Good Luck...Be back in Q3 [or earlier if Barry delivers]
Subject: Exciting News – CDMO Orders for Skincare Products to the Dominican Republic!
— SOHM, Inc. (@sohminc) February 8, 2024
Dear Stakeholders,
We are thrilled to announce that yesterday, we received significant CDMO (Contract Development and Manufacturing Organization) orders for the export of two of our premium…
thanks Mike, gl to you also....
now get back to rowing...lol...
I'll wish u luck since we are in the same boatload...I mean boat lol
After COGS they only made around $50k. Thats pretty pathetic
Good luck Myth! You’re gonna need it.
yeah right, let me explain something to you MP, I don't need to convince you of anything, or your buddy, I have a ton of shares and expect to make a ton of money here later this year.
wish me luck !
as far as Q1...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173792393
Very possible, and please don't try to convince me this is a great investment
wrong again, it's not even close to a " nice little flipping stock "......
did you flip those 16's yet ??
lol....
TWEET
SOHM, Inc.
@sohminc
SOHM, Inc. Reports Strong Q1 2024 Performance
In its recently published Quarter 1, 2024 report,
http://otcmarkets.com/financialReportViewer?id=402079
SOHM, Inc. highlights significant improvements in key financial metrics. Here's a more detailed breakdown:
Revenue Growth (83% MoM):
SOHM achieved an impressive 83% month-over-month (MoM) increase in revenues. This growth underscores the effectiveness of the company's sales efforts and the strong demand for its products in the market.
Gross Profit Margin (42% MoM):
The company's gross profit margin improved to 42% MoM. This positive trend reflects efficient cost management and successful pricing strategies. SOHM has strengthened its financial position by optimizing production costs and pricing structures.
Net Profit and R&D Expenses:
Despite declining net profit due to recent research and development (R&D) expenses, SOHM's management anticipated this outcome. Investments in R&D are crucial for long-term growth and innovation. Notably, the company's acquisition of the ABBIE gene-editing technology positions it well for future advancements.
Operational Expansion (Carlsbad Plant):
The operational Carlsbad plant represents a significant milestone for SOHM. The company aims to maximize production capacity and streamline distribution processes as it continues to operate. Simultaneously, efforts are underway to secure permission for the San Diego facility, further enhancing SOHM's capabilities.
International and Domestic Orders:
SOHM has successfully secured contract development and manufacturing organization (CDMO) orders for exports to Latin American countries. This expansion into new markets is a promising sign for future growth and global reach.
Solid Dose Rx Product Distribution:
SOHM is actively negotiating additional solid dose Rx product distribution agreements. These products are in high demand in the USA market. Alongside the existing Levetiracetam distribution, the company continues to explore new opportunities that align with its vision.
Nutraceutical Products:
SOHM's nutraceutical products, branded under the SOHM label, will soon be available on its official website and Amazon store. Additionally, discussions are ongoing regarding distribution to major retail brick-and-mortar chain stores. This diversification aims to tap into the growing health and wellness market.
Overall, management and leadership remain optimistic about its prospects for the coming quarters. The company's commitment to quality, innovation, and strategic planning positions it well for continued success.
$SHMN
12:45 AM · May 14, 2024
Actually, I meant 300k. Lol, but it doesn't matter. They couldn't even reach that.
Sohm is not really a player in the business world. I don't expect we ever see much.
Nice little flipping stock at this point
you thought 3 ml ?
lol....
change your mind ?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174399014
I thought at least 3 million , way under what I thought
Chart was expecting 1.2 million so pretty sure he won't be happy
Not going to lie, I was expecting more. Was hoping they would get more of that CDMO order out. This Baby Pharma is still crawling, need them to stand up and take some Baby Steps. (That amount to real Revenues.)
Of course, we're all here for some kind of news that busts us over .002 for good, imo. hL. Shmn
Strong (not-so-strong-imo) 1Q 2024 $89,894.
https://www.otcmarkets.com/stock/SHMN/disclosure
SOHM, Inc. Reports Strong Q1 2024 Performance
— SOHM, Inc. (@sohminc) May 14, 2024
In its recently published Quarter 1, 2024 report, https://t.co/C13hqVhr3W
SOHM, Inc. highlights significant improvements in key financial metrics. Here's a more detailed breakdown:
Revenue Growth (83% MoM):
SOHM achieved an…
How was the revenue
Filing is out. So much for those outlandish revenue predictions
Good question. It looks like they "attended" DCAT week in March:
We are attending DCAT week at New York, please see below and get in touch for CDMO, Levetiracetam, Topical products, etc. #DCATweek#Levetiracetam #CDMO$SHMN pic.twitter.com/0lXrJbsMIh
— SOHM, Inc. (@sohminc) March 6, 2024
We’re thrilled to announce that our presentation at #AACR was met with an exceptional reception. It was an honor to showcase our technology to esteemed researchers and leaders in the biotech industry.
— SOHM, Inc. (@sohminc) April 9, 2024
The overwhelming interest and impact generated by our innovation have been… pic.twitter.com/50Ggv6hqPj
Which begs the question, how definitive was it?
No prize, just a friendly bet
I guess it doesn't matter now being it was 2021, I just feel as though they didn't " get over their skis " as the Definitive agreement was announced..
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Signed-a-Definitive-Agreement-for-Acquisition-of-Californian-Pharmaceutical-Company?id=323160
Now what actually happened as far as why it broke down was never explained although I was told the seller wanted more money which should have costed them in penalties.
Did it ? Who knows....
It's been a good couple of years, that's for sure. Before that, pretty hit or miss.
Snowbird is still open, and from the look of things, several other areas *could* have stayed open had they wanted to (by this time of year, most of the skiers have season passes, so there's little financial incentive to keep operating)
Yes, and the lack of disclosure was a major concern of mine during this period.
That said, a LOI is not a definitive agreement, and based on what they did disclose, the definitive was never executed (they seemed to have a couple of 'agreements to agree', which are unenforceable and thus not definitive).
Synbiobeta conference was last week.
https://www.synbiobeta.com/attend/synbiobeta-2024#speakers
Wasn't Sohm touting their participation at the conference a few months ago?
$SHMN: MPSTOCK: Now having said all of that...
Let's give some credit where it's due.
1. ABBIE (Gene Editing) acquisition of IP will take this Co to a different playing field.
2. ABBIE & CoStar's Red blood cell membrane will make this COMBO as a SUPERIOR mode of Bioavailability...meaning that this combo will simply outperform other types of gene therapy delivery (Most drugs FAIL in the realm of Bioavailability, they show promise in a petri-dish...but...)
The PPS here IMO won't run on Rx Revenue, but even with the slightest hint of a partnership with a Mid to Large biotech... it'll trade way higher.
BTW:- Anyone here in touch with the company needs to tell them to PATENT (Method Claim at least) the COMBO of ABBIE + CoStar (RBC Membrane).
This will prevent anyone else from leveraging on this combo.
$SHMN: MPSTOCK : My Revenue guesstimate is based on the Honorable Leader's OWN projections👇
I'm only factoring in 10% of his "Projections" (Filthy Lies).
Time to put up or GTFO
It is in a preliminary stage but aligns with the company’s growth plan and rebranding strategy. The company has projected $10,000,000 in annual gross sales over the next 12 months. $SHMN (2/2)
— SOHM, Inc. (@sohminc) July 28, 2022
SOHM Inc. is pleased to announce that based on the successful completion of previous orders, the company has received new forecasting and orders estimated at $750,000 for the next 3 quarters from one of the customers. $SHMN
— SOHM, Inc. (@sohminc) March 15, 2022
I have a friendly bet with another SOHM investor that revenue will be 370 k and his guess is 1.2 million
Might as well have a little fun here
*takes me back. :)
"Getting out over their skis."
Tales me back to my younger days on the slopes. Used to do that regularly, all speed and not enough skill/technique. I'm assuming you've had some fun on the powder up in your corner of the US.
Agree with your assessment too, regarding the whole deal with Dhan M.
HL. Shmn
Hey JD, isn't a Definitive Agreement required to be disclosed as a Material Event within 4 business days ?
The fact ( as I understand it ) that either company can still bail is what puzzles me, in this case I heard the seller here demanded a higher price at closing.
What even puzzles me more is that SHMN didn't just inform the public of what actually happened, when it happened. With the share count not changing what would be the purpose of being silent as the shareholders are staring in disbelief ?
Unless the goal is to pump
$SHMN: If they partner with a LARGE Pharma-BioTech, regarding ABBIE...
The Sky's the limit. CoStar + ABBIE is a winning combo.👇️
So they will be able to attract mid-size to Large Bio-TECHs for licensing + Partnership.
https://interestingengineering.com/health/regain-hearing-new-gene-therapy?utm_source=facebook&utm_medium=article_image
To be fair, M&A is difficult, and is frequently derailed at the last minute. I've been involved in more than one near miss involving much larger, better established, and more successful organizations.
Their biggest failing is getting out over their skis before the material deal terms were solidified. Unless the goal is to pump, it's always better for a pubco to wait to disclose these types of transactions until there is greater clarity/more likelihood of closing.
Followers
|
482
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
65770
|
Created
|
06/10/09
|
Type
|
Free
|
Moderators Myth MDPennyPlayer |
Website: http://www.sohm.com
TWITTER FEED: https://twitter.com/sohminc?lang=en
FACEBOOK FEED: https://www.facebook.com/sohminc/
PRESS RELEASES (SOHM Website): https://www.sohm.com/category/press-releases/
NVSOS: http://nvsos.gov/SOSEntitySearch/CorpDetails.aspx?lx8nvq=DraWvY7hzMLlBgmKhjdRSQ%253d%253d&nt7=0
NVSOS ACTIONS/AMENDMENTS: http://nvsos.gov/SOSEntitySearch/corpActions.aspx?lx8nvq=DraWvY7hzMLlBgmKhjdRSQ%253d%253d&CorpName=SOHM%2c+INC.
Contact info.
Phone: (714) 522-6700
Address:
4195 Chino Hills Pkway
Ste 675
Chino Hills, CA 91709
Email: info@sohm.com
SHMN RECENT NEWS
SOHM Announces Its Acquisition of ABBIE, a World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors
https://www.globenewswire.com/news-release/2023/09/26/2749662/0/en/SOHM-Announces-Its-Acquisition-of-ABBIE-a-World-Class-Gene-Editing-Platform-Which-Can-Deliver-Genetic-Payloads-Using-Non-Viral-Vectors.html
SOHM Collaborates with University of Arizona Center for Innovation to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |